ReviewFuture medicinal chemistry2025

Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception.

Jeanine Giarolla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.